Literature DB >> 17596776

Effect of energy deficiency on estrogen metabolism in premenopausal women.

Kim C Westerlind1, Nancy I Williams.   

Abstract

PURPOSE: Physical activity has been associated with decreased breast cancer risk, potentially through changes in estrogen metabolism. Two-hydroxyestrone (2-OHE1) and 16alpha-hydroxyestrone (16alpha-OHE1) have different biological properties, and the ratio of these metabolites (2/16) has been proposed to predict breast cancer risk. Diet and exercise have been found to influence estrogen metabolism, particularly when a state of negative energy balance is achieved. We sought to determine whether 4 months of moderate-intensity exercise coupled with calorie restriction would result in changes in urinary 2-OHE1, 16alpha-OHE1, or 2/16 in sedentary, premenopausal, eumenorrheic women.
METHODS: Average age was 31.5 yr, average body fat was 31.6%, and average BMI was 23.7. Urinary estrogen metabolites were measured in 24 women during the baseline and for four intervention months in the midfollicular and midluteal phases.
RESULTS: The intervention produced a significant drop in body fat (4.5%) and body weight (3.7 kg). Aerobic fitness increased significantly (26%; P < 0.001). Overall, there were no significant effects of the diet and exercise intervention on 2-OHE1, 16alpha-OHE1, or 2/16. However, when divided into tertiles according to baseline 2/16, the intervention resulted in significant increases in 2/16 in women in the lowest tertile. Women in the lowest tertile (average 2/16 = 0.91) did not differ from the other tertiles in baseline estradiol concentrations, body fat, weight, fitness, or changes in these variables with the intervention.
CONCLUSION: The data suggest that women at higher risk for developing breast cancer because of low 2/16 may reduce their risk by participating in lifestyle interventions such as exercise/calorie restriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596776     DOI: 10.1097/mss.0b013e3180485727

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

1.  The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.

Authors:  Alma J Smith; William R Phipps; William Thomas; Kathryn H Schmitz; Mindy S Kurzer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05       Impact factor: 4.254

2.  Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.

Authors:  Nicola Napoli; Swapna Vattikuti; Jayasree Yarramaneni; Tusar K Giri; Srenath Nekkalapu; Clifford Qualls; Reina C Armamento-Villareal
Journal:  Maturitas       Date:  2012-03-03       Impact factor: 4.342

3.  Energy Availability Is Associated With Luteinizing Hormone Pulse Frequency and Induction of Luteal Phase Defects.

Authors:  Kristen J Koltun; Mary Jane De Souza; Jennifer L Scheid; Nancy I Williams
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

4.  Magnitude of daily energy deficit predicts frequency but not severity of menstrual disturbances associated with exercise and caloric restriction.

Authors:  Nancy I Williams; Heather J Leidy; Brenna R Hill; Jay L Lieberman; Richard S Legro; Mary Jane De Souza
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

5.  Estrogen and progesterone exposure is reduced in response to energy deficiency in women aged 25-40 years.

Authors:  N I Williams; J L Reed; H J Leidy; R S Legro; M J De Souza
Journal:  Hum Reprod       Date:  2010-07-06       Impact factor: 6.918

6.  Menstrual Disruption with Exercise Is Not Linked to an Energy Availability Threshold.

Authors:  Jay L Lieberman; Mary Jane DE Souza; David A Wagstaff; Nancy I Williams
Journal:  Med Sci Sports Exerc       Date:  2018-03       Impact factor: 5.411

7.  The manner in which calories are restricted impacts mammary tumor cancer prevention.

Authors:  Margot P Cleary; Michael E Grossmann
Journal:  J Carcinog       Date:  2011-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.